| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S004030050125 |
| P698 | PubMed publication ID | 8931872 |
| P2093 | author name string | R Knobler | |
| F Trautinger | |||
| G Klosner | |||
| M Pourmojib | |||
| P Neuner | |||
| P2860 | cites work | Modulation of squamous carcinoma cell growth, morphology, adhesiveness and extracellular matrix production by interferon-gamma and tumor necrosis factor-alpha | Q68379351 |
| In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies | Q72037662 | ||
| Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms | Q72775069 | ||
| Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy | Q72964621 | ||
| Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor | Q24304040 | ||
| Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence | Q28300302 | ||
| Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice | Q28593915 | ||
| Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor | Q33739657 | ||
| A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor | Q33864621 | ||
| Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients | Q33891111 | ||
| Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes | Q34567983 | ||
| Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo | Q37031936 | ||
| The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation | Q40333028 | ||
| Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor | Q40348334 | ||
| IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines | Q40776887 | ||
| High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia | Q41020010 | ||
| Selective release of tumor necrosis factor binding protein II by malignant human epidermal cells reveals protection from tumor necrosis factor alpha-mediated cytotoxicity | Q41429029 | ||
| Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation | Q41508854 | ||
| Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis | Q41650994 | ||
| Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancy | Q46676462 | ||
| Selective species specificity of tumor necrosis factor for toxicity in the mouse. | Q49168975 | ||
| Polypetide mediator network | Q59073978 | ||
| Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus | Q61628148 | ||
| Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients | Q68256254 | ||
| 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression | Q68318344 | ||
| P433 | issue | 11 | |
| P921 | main subject | TNF | Q18032037 |
| P304 | page(s) | 691-696 | |
| P577 | publication date | 1996-10-01 | |
| P1433 | published in | Archives of Dermatological Research | Q18616385 |
| P1476 | title | Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p75 mRNA. | |
| P478 | volume | 288 |
Search more.